BioCryst Closes $23 Million Senior Credit Facility
Cash runway extended to early 2018; Facility to be repaid with RAPIVAB revenues RESEARCH TRIANGLE PARK, N.C., Sept. 26, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the Company has closed a $23 million …